Mifegyne

Known as: Contragest Brand of Mifepristone, Exelgyn Brand of Mifepristone, Mifégyne 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1988-2017
01219882017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
OBJECTIVES To offer a therapeutic management of cesarean scar pregnancies (GSC) in the first trimester of pregnancy with a first… (More)
  • figure 1
  • figure 2
Is this relevant?
Review
2006
Review
2006
OBJECTIVES To collect information about how private physicians in South Africa provide medication abortion services to their… (More)
Is this relevant?
1999
1999
The substance Mifegyne, an antigestagen, can profoundly influence progesterone-dependent situations given the relevant… (More)
Is this relevant?
1994
1994
In the fall of 1992, an abortifacient, mifepristone (Mifegyne), was introduced in Sweden. Mifepristone is an antiprogesterone… (More)
Is this relevant?
1992
1992
Reversible ventricular fibrillation occurred in a 35 year old multiparous woman after the administration of the association… (More)
Is this relevant?
1992
1992
  • Journal Officiel De La Republique Francaise…
  • 1992
This Order sets forth rules on the proper management of Mifegyne (RU 486) in France. Under its first section, manufacturers and… (More)
Is this relevant?
Review
1990
Review
1990
Mifepristone (Mifegyne 200 mg) is a newly approved drug in France for termination of early pregnancy. Consequently, doctors and… (More)
Is this relevant?
Review
1990
Review
1990
Progesterone receptor antagonists have been developed by substitutions at the 11-beta and 17 side-chain positions of the… (More)
Is this relevant?
Review
1988
Review
1988
Animal and human volunteer research involving the hormone antagonist Mifegyne (mifepristone) is reviewed. Studies in animals and… (More)
Is this relevant?
1988
1988
  • Annual review of population law
  • 1988
This French Order has been made having regard to an Order of 22 November 1988 inserting Mifepristone (RU 486) in division II of… (More)
Is this relevant?